Previous studies have demonstrated that ESR1 exerts hepatoprotective effects during liver carcinogenesis by delaying hepatocyte apoptosis, ameliorating hepatic fibrosis, and inhibiting tumor growth via ESR1-mediated signaling, thereby reducing HCC susceptibility (59). Here, ESR1 is linked to hepatocellular carcinoma.